Clinical Trial Update: Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis

View source ↗

Summary

This clinical trial update describes a flow cytometry-based neutrophil biomarker test intended to predict clinical benefit from immunotherapy across multiple ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Melanoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma
• Triple-negative Breast Cancer

Snippet

Sponsor: OncoHost Ltd. | Conditions: Non Small Cell Lung Cancer (NSCLC), Melanoma (Skin Cancer) | Status: NOT_YET_RECRUITING